Zobrazeno 1 - 10
of 21
pro vyhledávání: '"William W Abraham"'
Publikováno v:
7.3 Cystic Fibrosis.
Rationale: Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are associated with increased concentrations of airway neutrophil elastase. One of the consequences of this elastase increase is slowed mucus clearance. To model the pat
Autor:
Yuchuan Wu, Paul Morgan, Nathan O. Fuller, Wei Li, Samuel J. Goldman, Raveglia Luca Francesco, Cara M. M. Williams, Rustem Krykbaev, Joseph P. Sypek, Kristina Cunningham, Junjun Wu, William W Abraham, Fabio Rancati, Xin Xu, Steve Tam, Jianchang Li, Susan Fish, Tarek S. Mansour, Stefania Vallese, Rajeev Hotchandani
Publikováno v:
Journal of medicinal chemistry. 52(17)
MMP-12 plays a significant role in airway inflammation and remodeling. Increased expression and production of MMP-12 have been observed in the lungs of asthmatic patients. Compound 27 was identified as a potent and selective MMP-12 inhibitor possessi
Publikováno v:
Agents and actions. 13(1)
We investigated the modification of histamine-induced bronchoconstriction by the H2-antagonist cimetidine in conscious sheep. One hundred breaths of 5% histamine aerosol increased mean (SD) pulmonary resistance (RL) by 5.6 (1.4) cmH2O/l/sec. This inc
Autor:
William W Abraham, Adam Wanner
Publikováno v:
Lung. 160(5)
Ideally, animal models of bronchial asthma should exhibit most if not all features of human bronchial asthma. The general aim of developing such animal models has undoubtedly been to reproduce the human disease in order to study its pathophysiology a
Autor:
Cohen DJ; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA dcohen@crf.org.; Department of Cardiology, St. Francis Hospital and Heart Center, Roslyn, New York, USA., Wang K; Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA., Magnuson E; Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA., Smith R; Cardiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK., Petrie MC; University of Glasgow Institute of Cardiovascular and Medical Sciences, Glasgow, UK.; Golden Jubilee National Hospital, Clydebank, UK., Buch MH; Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester, Greater Manchester, UK., Abraham W; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA., Lindenfeld J; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mack MJ; Baylor Scott & White The Heart Hospital Plano, Plano, Texas, USA., Stone GW; The Zena & Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Cardiovascular Research Foundation, New York, New York, USA., Cleland JGF; University of Glasgow Robertson Centre for Biostatistics, Glasgow, UK.; National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College London, London, UK.
Publikováno v:
Heart (British Cardiac Society) [Heart] 2022 May; Vol. 108 (9), pp. 717-724. Date of Electronic Publication: 2022 Jan 25.
Publikováno v:
JACC. Heart failure [JACC Heart Fail] 2021 Nov; Vol. 9 (11), pp. 855-857.
Autor:
Brener MI; Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA., Grayburn P; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA., Lindenfeld J; Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Burkhoff D; Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA; Cardiovascular Research Foundation, New York, New York, USA., Liu M; Cardiovascular Research Foundation, New York, New York, USA., Zhou Z; Cardiovascular Research Foundation, New York, New York, USA., Alu MC; Cardiovascular Research Foundation, New York, New York, USA., Medvedofsky DA; Cardiovascular Core Laboratory, MedStar Health Research Institute, Washington, District of Columbia, USA., Asch FM; Cardiovascular Core Laboratory, MedStar Health Research Institute, Washington, District of Columbia, USA., Weissman NJ; Cardiovascular Core Laboratory, MedStar Health Research Institute, Washington, District of Columbia, USA., Bax J; Heart Lung Center, Leiden University Medical Center, Leiden, the Netherlands., Abraham W; Davis Heart and Lung Research Institute, The Ohio State University Medical Center, Columbus, Ohio, USA., Mack MJ; Baylor Scott & White Heart and Vascular Hospital, Plano, Texas, USA., Stone GW; Cardiovascular Research Foundation, New York, New York, USA; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Hahn RT; Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA. Electronic address: rth2@cumc.columbia.edu.
Publikováno v:
JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2021 Oct 25; Vol. 14 (20), pp. 2231-2242.
Autor:
Guha A; Cardio-Oncology Program, Division of Cardiology, Ohio State University, Columbus, OH, USA.; Harrington Heart and Vascular Institute, Case Western Reserve University, Cleveland, OH, USA., Dey AK; National Heart, Lung, and Blood Institute, Bethesda, MD, USA., Armanious M; Cardio-Oncology Program, Division of Cardiovascular Medicine, University of South Florida Morsani College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Dodd K; Cardio-Oncology Program, Division of Cardiology, Ohio State University, Columbus, OH, USA., Bonsu J; Cardio-Oncology Program, Division of Cardiology, Ohio State University, Columbus, OH, USA., Jneid H; Division of Cardiology, Michael E. DeBakey VA Hospital, Baylor College of Medicine, Houston, TX, USA., Abraham W; Cardio-Oncology Program, Division of Cardiology, Ohio State University, Columbus, OH, USA., Fradley MG; Cardio-Oncology Program, Division of Cardiovascular Medicine, University of South Florida Morsani College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Addison D; Cardio-Oncology Program, Division of Cardiology, Ohio State University, Columbus, OH, USA.; Cancer Control Program, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Publikováno v:
ESC heart failure [ESC Heart Fail] 2019 Aug; Vol. 6 (4), pp. 733-746. Date of Electronic Publication: 2019 Jul 02.
Autor:
Khayat R; Sleep Heart Program, Ohio State University, Columbus, OH 43210, USA. rami.khayat@osumc.edu, Abraham W, Patt B, Brinkman V, Wannemacher J, Porter K, Jarjoura D
Publikováno v:
Journal of cardiac failure [J Card Fail] 2012 Jul; Vol. 18 (7), pp. 534-40.
Autor:
Peacock WF; The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. Peacocw@ccf.org, Braunwald E, Abraham W, Albert N, Burnett J, Christenson R, Collins S, Diercks D, Fonarow G, Hollander J, Kellerman A, Gheorghiade M, Kirk D, Levy P, Maisel A, Massie BM, O'Connor C, Pang P, Shah M, Sopko G, Stevenson L, Storrow A, Teerlink J
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2010 Jul 27; Vol. 56 (5), pp. 343-51.